{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:05Z","timestamp":1793350805673,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.coi.2023.102398","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:29:33Z","timestamp":1700094573000},"page":"102398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Recent advances in enterotoxin vaccine adjuvants"],"prefix":"10.1016","volume":"85","author":[{"given":"Jessica W","family":"Crothers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2023.102398_bib1","doi-asserted-by":"crossref","first-page":"e00215","DOI":"10.1128\/mSphere.00215-18","article-title":"The mucosal vaccine adjuvant LT(R192G\/L211A) or dmLT","volume":"3","author":"Clements","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.coi.2023.102398_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2023.102398_sbref3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.vaccine.2019.02.025","article-title":"Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge","volume":"37","author":"Harro","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib4","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2018.11.040","volume":"37","author":"Akhtar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(19)30571-7","article-title":"Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1\/2 trial","volume":"20","author":"Qadri","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2023.102398_sbref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2021.10.056","article-title":"Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants","volume":"40","author":"Svennerholm","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref7","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1016\/j.vaccine.2021.08.032","article-title":"Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli","volume":"39","author":"Lee","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref8","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.vaccine.2022.03.056","volume":"40","author":"Crothers","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.vaccine.2023.01.048","article-title":"Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study","volume":"41","author":"Erdem","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib10","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib11","doi-asserted-by":"crossref","first-page":"S821","DOI":"10.1093\/infdis\/jiab475","article-title":"Mucosal immune responses against an oral enterotoxigenic Escherichia coli vaccine evaluated in clinical trials","volume":"224","author":"Svennerholm","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2023.102398_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125102","article-title":"Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study","volume":"14","author":"Walker","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102398_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.vaccine.2019.11.047","article-title":"A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(alphaK): a phase II study","volume":"38","author":"Pan","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102398_bib16","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/IAI.73.10.6892-6902.2005","article-title":"Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract","volume":"73","author":"van Ginkel","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2023.102398_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139368","article-title":"Nasal administration of cholera toxin as a mucosal adjuvant damages the olfactory system in mice","volume":"10","author":"Fukuyama","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102398_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010177","article-title":"A multi-epitope fusion antigen candidate vaccine for enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model","volume":"16","author":"Jones","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coi.2023.102398_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-019-0116-6","article-title":"The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine","volume":"4","author":"Liang","year":"2019","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2023.102398_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224073","article-title":"Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G\/L211A) by intradermal immunization in mice","volume":"14","author":"Maciel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102398_bib21","article-title":"Evaluation of the immunogenicity and protective efficacy of an enterotoxigenic Escherichia coli CFA\/I adhesin-heat-labile toxin chimera","volume":"88","author":"O\u2019Dowd","year":"2020","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2023.102398_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00228-w","article-title":"Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments","volume":"5","author":"Poncet","year":"2020","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2023.102398_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.vaccine.2020.12.034","article-title":"Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model","volume":"39","author":"Ramakrishnan","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.vaccine.2023.01.033","article-title":"Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients","volume":"41","author":"Stone","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/vaccines10020241","article-title":"Vaccine candidate double mutant variants of enterotoxigenic Escherichia coli heat-stable toxin","volume":"10","author":"Zegeye","year":"2022","journal-title":"Vaccines(Basel)"},{"key":"10.1016\/j.coi.2023.102398_bib26","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","article-title":"Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104229","article-title":"Oral immunization of BALB\/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection","volume":"145","author":"Zhong","year":"2020","journal-title":"Micro Pathog"},{"key":"10.1016\/j.coi.2023.102398_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202938119","article-title":"A polyvalent multiepitope protein cross-protects against Vibrio cholerae infection in rabbit colonization and passive protection models","volume":"119","author":"Upadhyay","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2023.102398_bib29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.1800985","article-title":"A combined YopB and LcrV subunit vaccine elicits protective immunity against Yersinia infection in adult and infant mice","volume":"202","author":"Heine","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4269\/ajtmh.19-0798","article-title":"Transcutaneous vaccination with conjugate typhoid vaccine Vi-DT induces systemic, mucosal, and memory anti-polysaccharide responses","volume":"103","author":"Bhuiyan","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2023.102398_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00296-20","article-title":"Immunization with a biofilm-disrupting nontypeable Haemophilus influenzae vaccine antigen did not alter the gut microbiome in chinchillas, unlike oral delivery of a broad-spectrum antibiotic commonly used for otitis media","volume":"5","author":"Bailey","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.coi.2023.102398_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019923118","article-title":"Immunization with HMW1 and HMW2 adhesins protects against colonization by heterologous strains of nontypeable Haemophilus influenzae","volume":"118","author":"Kadry","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2023.102398_bib33","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.vaccine.2020.01.052","article-title":"Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity","volume":"38","author":"Novotny","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_sbref34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1198","article-title":"Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling","volume":"6","author":"Iwanaga","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib35","article-title":"The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice","volume":"13","author":"Molina Estupinan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.vaccine.2018.12.053","article-title":"Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia","volume":"37","author":"Baker","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00555-20","article-title":"Optimization of an experimental vaccine to prevent Escherichia coli urinary tract infection","volume":"11","author":"Forsyth","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.coi.2023.102398_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119348","article-title":"Prevention of influenza virus infection and transmission by intranasal administration of a porous maltodextrin nanoparticle-formulated vaccine","volume":"582","author":"Quan Le","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coi.2023.102398_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51356-w","article-title":"LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (muMT) mice","volume":"9","author":"Valli","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2023.102398_bib40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1089\/aid.2020.0157","article-title":"Comparative evaluation of prophylactic SIV vaccination modalities administered to the oral cavity","volume":"36","author":"Chaudhary","year":"2020","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.coi.2023.102398_sbref41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4102","article-title":"A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques","volume":"7","author":"Sahoo","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253265","article-title":"Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs","volume":"16","author":"Tunggal","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102398_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010323","article-title":"Conserved metabolic enzymes as vaccine antigens for giardiasis","volume":"16","author":"Ihara","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coi.2023.102398_bib44","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/pharmaceutics14112290","article-title":"An immunconjugate vaccine alters distribution and reduces the antinociceptive, behavioral and physiological effects of fentanyl in male and female rats","volume":"14","author":"Haile","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coi.2023.102398_sbref45","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00329-0","article-title":"Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge","volume":"6","author":"Stone","year":"2021","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.coi.2023.102398_bib46","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.vaccine.2023.01.005","article-title":"Identifying a stable bulk dmLT adjuvant formulation at a clinically relevant concentration","volume":"41","author":"Estrada","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2023.102398_bib47","doi-asserted-by":"crossref","first-page":"13440","DOI":"10.3390\/ijms232113440","article-title":"Mucosal adjuvants delivered by a mucoadhesive patch for sublingual administration of subunit vaccines","volume":"23","author":"Monge","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2023.102398_bib48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s13346-021-00964-z","article-title":"Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery","volume":"11","author":"Oh","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.coi.2023.102398_sbref49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.647873","article-title":"A systems biology approach identifies B Cell Maturation Antigen (BCMA) as a biomarker reflecting oral vaccine induced IgA antibody responses in humans","volume":"12","author":"Mottram","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2023.102398_sbref50","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.immuni.2022.08.017","article-title":"Mucosal plasma cells are required to protect the upper airway and brain from infection","volume":"55","author":"Wellford","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2023.102398_bib51","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.immuni.2021.07.005","article-title":"Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy","volume":"54","author":"Bhattacharjee","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2023.102398_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/jimmunol.1801068","article-title":"Microbiota metabolite short-chain fatty acids facilitate mucosal adjuvant activity of cholera toxin through GPR43","volume":"203","author":"Yang","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxaa029","article-title":"Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccine","volume":"32","author":"Lan","year":"2020","journal-title":"Int Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227047","article-title":"LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms","volume":"15","author":"Valli","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2023.102398_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41385-020-0253-2","article-title":"The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization","volume":"13","author":"Schussek","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102398_sbref56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc5500","article-title":"Peyer's patch T(H)17 cells are dispensable for gut IgA responses to oral immunization","volume":"7","author":"Gribonika","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102398_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/imcb.12364","article-title":"Nasal vaccination of beta7 integrin-deficient mice retains elevated IgA immunity","volume":"98","author":"Maslanka","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.coi.2023.102398_bib58","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.2200221","article-title":"The adjuvant combination of dmLT and monophosphoryl Lipid A activates the canonical, nonpyroptotic NLRP3 inflammasome in dendritic cells and significantly interacts to expand antigen-specific CD4 T cells","volume":"210","author":"Bauer","year":"2023","journal-title":"J Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:48:18Z","timestamp":1760604498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791523001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":58,"alternative-id":["S0952791523001176"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2023.102398","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in enterotoxin vaccine adjuvants","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2023.102398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102398"}}